TrialDiabetes technology & therapeutics2022

A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes.

Roy W Beck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.